172 related articles for article (PubMed ID: 19198628)
1. Mek1/2 gene dosage determines tissue response to oncogenic Ras signaling in the skin.
Scholl FA; Dumesic PA; Barragan DI; Charron J; Khavari PA
Oncogene; 2009 Mar; 28(12):1485-95. PubMed ID: 19198628
[TBL] [Abstract][Full Text] [Related]
2. Mek1/2 MAPK kinases are essential for Mammalian development, homeostasis, and Raf-induced hyperplasia.
Scholl FA; Dumesic PA; Barragan DI; Harada K; Bissonauth V; Charron J; Khavari PA
Dev Cell; 2007 Apr; 12(4):615-29. PubMed ID: 17419998
[TBL] [Abstract][Full Text] [Related]
3. Constitutive activation of the MEK/ERK pathway mediates all effects of oncogenic H-ras expression in primary erythroid progenitors.
Zhang J; Lodish HF
Blood; 2004 Sep; 104(6):1679-87. PubMed ID: 15166036
[TBL] [Abstract][Full Text] [Related]
4. Selective role for Mek1 but not Mek2 in the induction of epidermal neoplasia.
Scholl FA; Dumesic PA; Barragan DI; Harada K; Charron J; Khavari PA
Cancer Res; 2009 May; 69(9):3772-8. PubMed ID: 19383924
[TBL] [Abstract][Full Text] [Related]
5. A novel MEK2/PI3Kδ pathway controls the expression of IL-1 receptor antagonist in IFN-β-activated human monocytes.
Brandt KJ; Carpintero R; Gruaz L; Molnarfi N; Burger D
J Leukoc Biol; 2010 Dec; 88(6):1191-200. PubMed ID: 20837746
[TBL] [Abstract][Full Text] [Related]
6. Functional redundancy of the kinases MEK1 and MEK2: Rescue of the Mek1 mutant phenotype by Mek2 knock-in reveals a protein threshold effect.
Aoidi R; Maltais A; Charron J
Sci Signal; 2016 Jan; 9(412):ra9. PubMed ID: 26814233
[TBL] [Abstract][Full Text] [Related]
7. p38 mitogen-activated protein kinase-dependent activation of protein phosphatases 1 and 2A inhibits MEK1 and MEK2 activity and collagenase 1 (MMP-1) gene expression.
Westermarck J; Li SP; Kallunki T; Han J; Kähäri VM
Mol Cell Biol; 2001 Apr; 21(7):2373-83. PubMed ID: 11259586
[TBL] [Abstract][Full Text] [Related]
8. Negative regulation of mTOR activation by diacylglycerol kinases.
Gorentla BK; Wan CK; Zhong XP
Blood; 2011 Apr; 117(15):4022-31. PubMed ID: 21310925
[TBL] [Abstract][Full Text] [Related]
9. Sef downregulation by Ras causes MEK1/2 to become aberrantly nuclear localized leading to polyploidy and neoplastic transformation.
Duhamel S; Hébert J; Gaboury L; Bouchard A; Simon R; Sauter G; Basik M; Meloche S
Cancer Res; 2012 Feb; 72(3):626-35. PubMed ID: 22298595
[TBL] [Abstract][Full Text] [Related]
10. Activated Ki-Ras suppresses 12-O-tetradecanoylphorbol-13-acetate-induced activation of the c-Jun NH2-terminal kinase pathway in human colon cancer cells.
Okumura K; Shirasawa S; Nishioka M; Sasazuki T
Cancer Res; 1999 May; 59(10):2445-50. PubMed ID: 10344756
[TBL] [Abstract][Full Text] [Related]
11. RNAi-mediated MEK1 knock-down prevents ERK1/2 activation and abolishes human hepatocarcinoma growth in vitro and in vivo.
Gailhouste L; Ezan F; Bessard A; Frémin C; Rageul J; Langouët S; Baffet G
Int J Cancer; 2010 Mar; 126(6):1367-77. PubMed ID: 19816936
[TBL] [Abstract][Full Text] [Related]
12. Elastin peptides activate extracellular signal-regulated kinase 1/2 via a Ras-independent mechanism requiring both p110gamma/Raf-1 and protein kinase A/B-Raf signaling in human skin fibroblasts.
Duca L; Lambert E; Debret R; Rothhut B; Blanchevoye C; Delacoux F; Hornebeck W; Martiny L; Debelle L
Mol Pharmacol; 2005 Apr; 67(4):1315-24. PubMed ID: 15653554
[TBL] [Abstract][Full Text] [Related]
13. Roles of the MEK1/2 and AKT pathways in CXCL12/CXCR4 induced cholangiocarcinoma cell invasion.
Leelawat K; Leelawat S; Narong S; Hongeng S
World J Gastroenterol; 2007 Mar; 13(10):1561-8. PubMed ID: 17461449
[TBL] [Abstract][Full Text] [Related]
14. MEK1/2 dual-specificity protein kinases: structure and regulation.
Roskoski R
Biochem Biophys Res Commun; 2012 Jan; 417(1):5-10. PubMed ID: 22177953
[TBL] [Abstract][Full Text] [Related]
15. Mek1 alters epidermal growth and differentiation.
Scholl FA; Dumesic PA; Khavari PA
Cancer Res; 2004 Sep; 64(17):6035-40. PubMed ID: 15342384
[TBL] [Abstract][Full Text] [Related]
16. Platelet factor 4 inhibits FGF2-induced endothelial cell proliferation via the extracellular signal-regulated kinase pathway but not by the phosphatidylinositol 3-kinase pathway.
Sulpice E; Bryckaert M; Lacour J; Contreres JO; Tobelem G
Blood; 2002 Nov; 100(9):3087-94. PubMed ID: 12384403
[TBL] [Abstract][Full Text] [Related]
17. Downstream effectors of oncogenic ras in multiple myeloma cells.
Hu L; Shi Y; Hsu JH; Gera J; Van Ness B; Lichtenstein A
Blood; 2003 Apr; 101(8):3126-35. PubMed ID: 12515720
[TBL] [Abstract][Full Text] [Related]
18. Roles of the Ras-MEK-mitogen-activated protein kinase and phosphatidylinositol 3-kinase-Akt-mTOR pathways in Jaagsiekte sheep retrovirus-induced transformation of rodent fibroblast and epithelial cell lines.
Maeda N; Fu W; Ortin A; de las Heras M; Fan H
J Virol; 2005 Apr; 79(7):4440-50. PubMed ID: 15767444
[TBL] [Abstract][Full Text] [Related]
19. MEK1/2 overactivation can promote growth arrest by mediating ERK1/2-dependent phosphorylation of p70S6K.
Guégan JP; Ezan F; Gailhouste L; Langouët S; Baffet G
J Cell Physiol; 2014 Jul; 229(7):903-15. PubMed ID: 24501087
[TBL] [Abstract][Full Text] [Related]
20. Activation of MEK1 or MEK2 isoform is sufficient to fully transform intestinal epithelial cells and induce the formation of metastatic tumors.
Voisin L; Julien C; Duhamel S; Gopalbhai K; Claveau I; Saba-El-Leil MK; Rodrigue-Gervais IG; Gaboury L; Lamarre D; Basik M; Meloche S
BMC Cancer; 2008 Nov; 8():337. PubMed ID: 19014680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
